Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 07:44:02 +0200Mon, 22 Apr 2024 12:48:00 +0200Human medicines European public assessment report (EPAR): Lemtrada, alemtuzumab, Date of authorisation: 12/09/2013, Revision: 24, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/lemtradaHuman medicines European public assessment report (EPAR): Lemtrada, alemtuzumab, Date of authorisation: 12/09/2013, Revision: 24, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/lemtradaMon, 22 Apr 2024 12:48:00 +0200Human medicineLemtrada : EPAR - Medicine overviewhttps://www.ema.europa.eu/system/files/documents/overview/h-3718-summary_en.pdfLemtrada : EPAR - Medicine overviewhttps://www.ema.europa.eu/system/files/documents/overview/h-3718-summary_en.pdfWed, 29 Jan 2020 01:00:00 +0100Human medicine